ArticleCurrent oncology (Toronto, Ont.)2012

EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer.

S Kamel-Reid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.